- Home
- ABR vs MNKD Comparison
ABR vs MNKD Comparison
Compare ABR & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABR | MNKD |
|---|---|---|
| Founded | 2003 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2004 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ABR | MNKD |
|---|---|---|
| Price | $8.45 | $5.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $11.10 | $10.08 |
| AVG Volume (30 Days) | ★ 3.3M | 2.8M |
| Earning Date | 10-31-2025 | 11-05-2025 |
| Dividend Yield | ★ 13.53% | N/A |
| EPS Growth | N/A | ★ 23.47 |
| EPS | ★ 0.80 | 0.10 |
| Revenue | ★ $552,909,000.00 | $313,787,000.00 |
| Revenue This Year | N/A | $21.54 |
| Revenue Next Year | N/A | $22.21 |
| P/E Ratio | ★ $11.14 | $60.68 |
| Revenue Growth | N/A | ★ 17.43 |
| 52 Week Low | $8.18 | $3.38 |
| 52 Week High | $14.55 | $7.07 |
Technical Indicators
Market Signals| Indicator | ABR | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 34.05 | 62.66 |
| Support Level | $8.76 | $5.59 |
| Resistance Level | $9.30 | $6.01 |
| Average True Range (ATR) | 0.29 | 0.19 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 9.68 | 86.93 |
Price Performance
Historical ComparisonAbout ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.